Secondary Logo

Journal Logo

You can read the full text of this article if you:

Institutional members access full text with Ovid®

Clinical Studies

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma

Faiena, Izak*; Comin-Anduix, Begoña; Berent-Maoz, Beata; Bot, Adrian§; Zomorodian, Nazy*; Sachdeva, Ankush*; Said, Jonathan; Cheung-Lau, Gardenia; Pang, Jia; Macabali, Mignonette; Chodon, Thinle; Wang, Xiaoyan#; Cabrera, Paula; Kaplan-Lefko, Paula; Chamie, Karim*; Belldegrun, Arie S.*; Pantuck, Allan J.*; Drakaki, Alexandra*,∥

Author Information
doi: 10.1097/CJI.0000000000000336
  • Buy
  • SDC


Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.